Close Menu

Genetic Research

News on genome-wide association studies, genotyping, metagenomics, basic research in genetics, genomics, and molecular diagnostics.

A Myriad Genetics-funded team found that an 86-SNV polygenic score could modify breast cancer risk in women with pathogenic mutations in cancer risk genes.

Christiana Care researchers have identified a unique protospacer adjacent motif site that allows them to knock out the NRF2 gene in tumor cells while leaving normal cells alone.

Polygenic risk scores have the potential to impact cancer screening, autoimmune disease testing, and therapeutics development, but more diverse data is needed.

The framework is meant to guide healthcare providers in facilitating prostate cancer genetic testing in a timely and responsible way, the researchers said.

New data shows that the test could eventually be useful in helping younger women avoid chemotherapy in the neoadjuvant setting.